Topical Application of Curcumin Orabase in Oral Submucous Fibrosis (OSMF)
Topical Application of Curcumin Incorporated in Orabase in OSMF Patients
Sponsor: SVS Institute of Dental Sciences
A PHASE2 clinical study on Oral Submucous Fibrosis, this trial is ongoing. The trial is conducted by SVS Institute of Dental Sciences and has accumulated 6 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE2
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE2
-
Feb 2018 — Jun 2018 [monthly]
Unknown Status PHASE2
Status: Active Not Recruiting → Unknown Status
▶ Show 1 earlier version
-
Jan 2017 — Feb 2018 [monthly]
Active Not Recruiting PHASE2
First recorded
Dec 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- SVS Institute of Dental Sciences
For direct contact, visit the study record on ClinicalTrials.gov .